Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia
β Scribed by Mohamed A. Kharfan-Dabaja; Julio C. Chavez; Khadija A. Khorfan; Javier Pinilla-Ibarz
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 119 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Although patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing second primary malignancies, including lung carcinoma, there is virtually no information about their clinical outcomes. To evaluate this, the authors reviewed their 20-year institutional e
T h e in vitro peripheral lymphocyte response to phytohemagglutinin (PHA) was correlated with the clinical and immunologic status in 44 patients with chronic lymphocytic leukemia. T h e mean lymphocyte response was only slightly below the normal range a t day 3 of culture in patients in remission;
## Abstract ## BACKGROUND Patients with chronic lymphocytic leukemia (CLL) that transforms to Richter syndrome (RS) frequently show atypical lymphocytes in bone marrow; however, a diagnosis of RS requires confirmation of the presence of sheets of large cells in bone marrow or lymph nodes. ## METH
## Abstract ## BACKGROUND The ubiquitinβproteasome pathway has been implicated in the pathogenesis of many hematologic malignancies. ## METHODS The authors measured proteasome peptidase activity levels in plasma samples from 225 patients with chronic lymphocytic leukemia (CLL) and correlated the